Ethics: Investigators' interests: what should trial participants be told?
Level V
Where this comes from
- Record sourced from PubMed, PMID 20125171.
- Also identified by DOI 10.1038/nrrheum.2009.264.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Minimizing the potential adverse effects of clinical investigators' financial conflicts of interest involves, in part, determining how much of an investigator's "business" should be disclosed to participants in research studies. What should be disclosed and why? How will we know if disclosure matters?
Medical subject headings
- Clinical Trials as Topic
- Conflict of Interest
- Disclosure